Les CFD sont des instruments complexes et sont accompagnés d’un risque élevé de pertes financières rapides en raison de l’effet de levier. 74 % des comptes d’investisseurs particuliers perdent de l’argent en tradant des CFD avec ce fournisseur. Vous devez déterminer si vous comprenez comment fonctionnent les CFD et si vous pouvez vous permettre de courir le risque élevé de perdre votre argent.

Close

Tradez Amgen AMGN

Vendre
 Acheter

 Graphique en direct de Amgen

5m 15m 30m 1h 4h 1d 1w

Principes de base des instruments

Weekly Search
Weekly
Daily
Date Fermer Changes % Variation Ouvrir un compte Haut Bas

Dernières nouvelles

Closing 2024
2024 Dec 26, 17:00

Semaine à venir : Clôture de l’année 2024 et premières données économiques de 2025

UK GDP
Dyogenes Diniz 2024 Dec 19, 16:00

Semaine à venir : Dernière semaine complète de 2024 sur les marchés financiers

Le Forex Indices
US interest rate and Europe inflation to guide market direction
Markets.com Support Team 2024 Dec 13, 22:00

Semaine à venir : Les taux d'intérêt américains et l'inflation en Europe déterminent l'orientation des marchés

Indices Le Forex
Dyogenes Diniz 2024 Dec 05, 16:00

Semaine à venir : L'inflation et les taux d'intérêt vont secouer les marchés cette semaine

Le Forex Indices
US Employment Rate
Markets.com Support Team 2024 Nov 28, 17:00

Semaine à venir :  L'emploi aux États-Unis devrait influencer le sentiment des marchés cette semaine.

Le Forex Indices
Eurozone inflation
Markets.com Support Team 2024 Nov 23, 16:00

Semaine à venir : L'inflation de la zone euro devrait confirmer une réduction des taux de la BCE en décembre

Le Forex Indices
Nvidia Blackwell AI Chips
Markets.com Support Team 2024 Nov 14, 16:00

Semaine à venir : La hausse de la tech table sur les résultats de Nvidia

Le Forex Indices
Markets.com Support Team 2024 Nov 07, 16:00

Semaine à venir : « Trump trade », données sur l'inflation, résultats de Disney

Le Forex Indices

Info

Spread

1.79

Spread (%)

0.6384 %

Effet de levier

1:5

Intérêt au jour le jour à l’achat

-0.0597 %

Intérêt au jour le jour à la vente

-0.0292 %

Devise

USD

Horaires de Trading

Markets closed

Vendredi

13:31 - 19:59

Lundi

13:31-19:59

Mardi

13:31-19:59

Mercredi

13:31-19:59

Jeudi

13:31-19:59

Analyse et statistiques

Ouvrir un compte

---

Fermeture précédente

---

Plus haut/plus bas des 52 dernières semaines

--- – ---

Capitalisation boursière

153757433856

Actions en circulation

537204992

Date de rapport d'activité (suivante)

1999-11-22

Rendement des div

2025-06-06

Date de détachement du dividende

2025-05-16

Le taux de dividende annuel à terme 

9.52

Le rendement de dividende annuel à terme

0.0323

EPS

7.55

En savoir plus sur cet instrument

Amgen Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for men and women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA and PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; Novartis Pharma AG to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Instruments connexes

Actif
Vendre
Acheter
% Variation

Tradez

Tradez

Tradez

Tradez
Instruments connexes
Trustpilot
RequestMessages5TimelineExceptionsViews0RouteQueries0Models0MailsGateSession
SettingsRequest history38.1.18PHP Version39.38msRequest Duration2MBMemory UsageGET params
status
200 OK
full_url
https://web-qa.staging.markets.com/params
controller_action
App\Http\Controllers\TrackingParams@fetch
Theme
Open Button Position
Hide Empty Tabs
Autoshow
Reset to defaults
status
200 OK
full_url
https://web-qa.staging.markets.com/params
action_name
controller_action
App\Http\Controllers\TrackingParams@fetch
uri
GET params
controller
App\Http\Controllers\TrackingParams@fetch
file
app/Http/Controllers/TrackingParams.php:11-31
middleware
web
duration
39.62ms
peak_memory
8MB
response
application/json
request_format
html
request_query
[]
request_request
[]
request_headers
  0 of 0   
array:14 [▼
  "cookie" => array:1 [▶
    0 => "mktv4_ip_override=id; mktloc=eyJpdiI6ImZ4MWNHZ1oxMmZsSkdPWStHWFNla1E9PSIsInZhbHVlIjoiRnhzbTIyWExVR0FZVTZzTXI1MWZ5cGxyUTY0ckJOWFFuR1FCSGN6MHN2d1o1dlZxTzBGODNsa0lyZTRtNEdCaiIsIm1hYyI6ImUyNmI2N2QxZThmZGI2MTFlYTU3ZGQ0YzhkYzk0OTExYzU4Y2E0NzI5MzZjNTlkY2U1NzM2NzFiZGRhMjlhMDUiLCJ0YWciOiIifQ%3D%3D; intent_group=%252Fid%252Finstrument%252Fexxon%252F; intent_instrument=exxon; firstURL=https://web-qa.staging.markets.com/pt/instrument/total/; lastURL=https://web-qa.staging.markets.com/pt/instrument/total/; XSRF-TOKEN=eyJpdiI6Im9zSnpPclp0Q3BldzNIZ0NTYjdreXc9PSIsInZhbHVlIjoiV29pRTR6VTJoN2RIcEVSVHdzNmJRQ0p2eWx6S2hueHZtMXFhYUpOaFRaUG5pK3hVRm8yRzBpQktIZjRIcS9MMjc5ZGMvdDRjZ3VkK3J0U05ENzNWc0VQeXByTDdUVlFFM0ZJL2xwTEQ3WjhIT0trcW9HeDJwY0pzYmU2aGd1RVkiLCJtYWMiOiIyMjk2ZDJlNDFmMzM1YzllNDI4M2RkNjdlNGI4NWQwOGY2MzE5N2EyNTM3MTIzOWU0NzUxNmI0NTk5MzFkNzJkIiwidGFnIjoiIn0%3D; laravel_session=eyJpdiI6IkZQOUZ1YzM4eE9oaHJ0ejlnb3orRHc9PSIsInZhbHVlIjoieFVVMm9oS1hKa3ZJRS9ZRU1rSitUT0xaV3FDQkQrZkFXME9wTnRuczl1bTdpeG1TWjlBdXhjaU1yVG13NE1wQldyQW51QzYrTEZ5bW9DWktmN0x1ckErZHdnRER4TzJPS0JybzNMK251dVhDS09LazVncHBOcFhGWklPM1BnZVQiLCJtYWMiOiI3ZWU1MDE0MDg3ZmJhMzFiMGIxNGM1OGU2NDYwMmE4NTAwMWM0NDRhYWY1MThiMDM1ZWRjODRiNTI1ZTA5YzdhIiwidGFnIjoiIn0%3D ◀mktv4_ip_override=id; mktloc=eyJpdiI6ImZ4MWNHZ1oxMmZsSkdPWStHWFNla1E9PSIsInZhbHVlIjoiRnhzbTIyWExVR0FZVTZzTXI1MWZ5cGxyUTY0ckJOWFFuR1FCSGN6MHN2d1o1dlZxTzBGODNsa0l ▶"
  ]
  "accept-encoding" => array:1 [▶
    0 => "gzip, deflate, br, zstd"
  ]
  "sec-fetch-dest" => array:1 [▶
    0 => "empty"
  ]
  "sec-fetch-mode" => array:1 [▶
    0 => "cors"
  ]
  "sec-fetch-site" => array:1 [▶
    0 => "same-origin"
  ]
  "accept" => array:1 [▶
    0 => "*/*"
  ]
  "sec-ch-ua-mobile" => array:1 [▶
    0 => "?0"
  ]
  "sec-ch-ua" => array:1 [▶
    0 => ""HeadlessChrome";v="129", "Not=A?Brand";v="8", "Chromium";v="129""
  ]
  "user-agent" => array:1 [▶
    0 => "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)"
  ]
  "sec-ch-ua-platform" => array:1 [▶
    0 => ""Windows""
  ]
  "cache-control" => array:1 [▶
    0 => "no-cache"
  ]
  "pragma" => array:1 [▶
    0 => "no-cache"
  ]
  "connection" => array:1 [▶
    0 => "keep-alive"
  ]
  "host" => array:1 [▶
    0 => "web-qa.staging.markets.com"
  ]
]
request_cookies
  0 of 0   
array:8 [▼
  "mktv4_ip_override" => null
  "mktloc" => "us,us"
  "intent_group" => null
  "intent_instrument" => null
  "firstURL" => null
  "lastURL" => null
  "XSRF-TOKEN" => "dbc4y15UKDm1AVgJJpv3plAbYv2uk1lX3X8PnWSp"
  "laravel_session" => "ftDmFP2x0EJy93aHomFgFoeC4Uk8c5SHjjCjUWZj"
]
response_headers
  0 of 0   
array:3 [▼
  "cache-control" => array:1 [▶
    0 => "no-cache, private"
  ]
  "date" => array:1 [▶
    0 => "Sat, 12 Apr 2025 15:07:31 GMT"
  ]
  "content-type" => array:1 [▶
    0 => "application/json"
  ]
]
session_attributes
  0 of 0   
array:4 [▼
  "_token" => "dbc4y15UKDm1AVgJJpv3plAbYv2uk1lX3X8PnWSp"
  "PHPDEBUGBAR_STACK_DATA" => []
  "_previous" => array:1 [▶
    "url" => "https://web-qa.staging.markets.com/params"
  ]
  "_flash" => array:2 [▶
    "old" => []
    "new" => []
  ]
]
    • Booting (28.2ms)time
    • Application (11.17ms)time
    • Routing (512μs)
    • 1 x Booting (71.6%)
      28.20ms
      1 x Application (28.37%)
      11.17ms
      1 x Routing (1.3%)
      512μs
      0 templates were rendered
        uri
        GET params
        middleware
        web
        controller
        App\Http\Controllers\TrackingParams@fetch
        file
        app/Http/Controllers/TrackingParams.php:11-31
        0 statements were executed0μs
              _token
              dbc4y15UKDm1AVgJJpv3plAbYv2uk1lX3X8PnWSp
              PHPDEBUGBAR_STACK_DATA
              []
              _previous
              array:1 [ "url" => "https://web-qa.staging.markets.com/params" ]
              _flash
              array:2 [ "old" => [] "new" => [] ]
              ClearShow all
              Date ↕MethodURLData
              #12025-04-12 15:07:29GET/fr/instrument/amgen/567
              #22025-04-12 15:07:31GET/csrf/ (ajax)
              #32025-04-12 15:07:31GET/params/ (ajax)